Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intravenous Ferric Carboxymaltose for Improvement of Metabolic Parameters and Vascular Function in T2DM-patients With Iron Deficiency

NCT01513369 is registered in ClinicalTrials.gov with GWT-TUD GmbH as lead sponsor.

NCT NCT01513369
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01513369 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intravenous Ferric Carboxymaltose for Improvement of Metabolic Parameters and Vascular Function in T2DM-patients With Iron Deficiency
Lead sponsor
GWT-TUD GmbH
Phase
Phase 3
Overall status
Completed
Start date
August 31, 2012
Completion date
April 30, 2019
Enrollment
152 (estimated)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

iron deficiency, type 2 diabetes mellitus